Pharmaron Beijing (03759) completes the placement of a total of 58.44 million shares, raising net proceeds of 1.319 billion Hong Kong dollars.

Pharmaron Beijing (03759) announced that all conditions have been met and the placement was completed on January 22, 2026. The placing agents have successfully placed a total of 58.44 million shares at a placing price of HK$22.82 per share with no less than 6 independent placees according to the terms and conditions of the placing agreement. The net proceeds from the placement amount to HK$1.319 billion, which will be utilized as follows: approximately 70% will be used for the company's project construction to strengthen the capacity and capabilities of the company's laboratory service facilities, drug process development, and production facilities; around 10% will be used to repay bank loans and other borrowings to optimize the company's capital structure; and about 20% will be used for working capital and other general corporate purposes.